1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Crocin-loaded liposomes sensitize MDA-MB 231 breast cancer cells to doxorubicin by inducing apoptosis
(
- Contribution to journal › Article
- 2022
-
Mark
Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin
(
- Contribution to journal › Article
-
Mark
Hydroxyapatite – A trojan horse in the delivery of apatite-binding cytostatics in bone cancer
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma
(
- Contribution to journal › Article
- 2020
-
Mark
P-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis
(
- Contribution to journal › Article
- 2017
-
Mark
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
(
- Contribution to journal › Article
- 2014
-
Mark
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
(
- Contribution to journal › Article
- 2012
-
Mark
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
(
- Contribution to journal › Article
- 2011
-
Mark
MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells
(
- Contribution to journal › Article
- 2009
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article